Sign In
Buy LEGN
$35.98
-0.300 (-0.83%)
At Close: Jun 03, 2026
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that the European Commission (EC) has granted approval of
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
08:00am, Thursday, 11'th Apr 2024
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Monday, May 13,
Why Legend Biotech (LEGN) Stock Might be a Great Pick
09:50am, Monday, 08'th Apr 2024
Legend Biotech (LEGN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FDA) has approved C
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
08:30am, Tuesday, 19'th Mar 2024
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today released its inaugural Environmental, Social & Governance (ESG) repo
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that the U.S. Food and Drug Administration (FDA) Oncologic
Legend Biotech Corporation (LEGN) Q4 2023 Earnings Call Transcript
12:09pm, Monday, 11'th Mar 2024
Legend Biotech Corporation (NASDAQ:LEGN ) Q4 2023 Earnings Conference March 11, 2024 8:00 AM ET Company Participants Jessie Yeung - Head of Investor Relations and Public Relations Ying Huang - Chief E
Next-gen leaders: The biotech stock set to soar on groundbreaking innovation
08:31am, Monday, 11'th Mar 2024
The biotech industry is evolving rapidly, with 2024 poised to be a year of significant advancements and opportunities. Amidst an uncertain macroeconomic environment, the biotech sector is gaining mome
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
07:00am, Monday, 11'th Mar 2024
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its fourth quarter and full year 2023 unaudited financial r
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
08:36am, Friday, 08'th Mar 2024
We have narrowed our search to five biotech stocks with strong potential for 2024. These are MOR, LEGN, ASND, EXEL and EXAS.
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the Committee for Medicinal Products for Human Use (CHMP)
FDA Demands "Boxed Warning" to CAR T-Cell Therapy Labels
09:10am, Tuesday, 23'rd Jan 2024
The FDA directs companies like NVS, BMY, GILD and others to add "boxed warning" to the labels of their CAR T-cell immunotherapies after it identified adverse events.
NANJING, China , Jan. 4, 2024 /PRNewswire/ -- GenScript Biotech, a global leader in life science research and manufacturing services, along with its subsidiaries GenScript ProBio and Legend Biotech, w
Legend Biotech Announces Closing of License Transaction for Certain CAR-T Therapies Targeting DLL3
08:30am, Wednesday, 03'rd Jan 2024
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing, and commercializing novel therapies to treat life
Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
08:30am, Tuesday, 02'nd Jan 2024
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing, and commercializing novel therapies to treat life
